These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1654399)
21. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains. Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764 [TBL] [Abstract][Full Text] [Related]
22. Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains. Arai Y; Mizuguchi M; Ikeda K; Takashima S Brain Res Dev Brain Res; 1995 Jul; 87(2):228-32. PubMed ID: 7586507 [TBL] [Abstract][Full Text] [Related]
23. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [TBL] [Abstract][Full Text] [Related]
24. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Dickson DW; Ruan D; Crystal H; Mark MH; Davies P; Kress Y; Yen SH Neurology; 1991 Sep; 41(9):1402-9. PubMed ID: 1653914 [TBL] [Abstract][Full Text] [Related]
25. Dystrophic neurites around amyloid plaques of human patients with Gerstmann-Sträussler-Scheinker disease contain ubiquitinated inclusions. Migheli A; Attanasio A; Vigliani MC; Schiffer D Neurosci Lett; 1991 Jan; 121(1-2):55-8. PubMed ID: 1708486 [TBL] [Abstract][Full Text] [Related]
26. An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Mann DM; Brown A; Prinja D; Davies CA; Landon M; Masters CL; Beyreuthers K Neuropathol Appl Neurobiol; 1989; 15(4):317-29. PubMed ID: 2528701 [TBL] [Abstract][Full Text] [Related]
27. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048 [TBL] [Abstract][Full Text] [Related]
28. Down's syndrome: occurrence of ALZ-50 reactive neurons and the formation of senile plaques. Sparks DL; Hunsaker JC J Neurol Sci; 1992 May; 109(1):77-82. PubMed ID: 1387679 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions. de la Monte SM; Wands JR J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363 [TBL] [Abstract][Full Text] [Related]
30. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261 [TBL] [Abstract][Full Text] [Related]
31. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease. de la Monte SM; Hedley-Whyte ET J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772 [TBL] [Abstract][Full Text] [Related]
32. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340 [TBL] [Abstract][Full Text] [Related]
33. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Pinter JD; Eliez S; Schmitt JE; Capone GT; Reiss AL Am J Psychiatry; 2001 Oct; 158(10):1659-65. PubMed ID: 11578999 [TBL] [Abstract][Full Text] [Related]
34. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Cummings BJ; Su JH; Cotman CW Exp Neurol; 1993 Dec; 124(2):315-25. PubMed ID: 8287930 [TBL] [Abstract][Full Text] [Related]
36. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796 [TBL] [Abstract][Full Text] [Related]
37. Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome. Spargo E; Luthert PJ; Anderton BH; Bruce M; Smith D; Lantos PL Neurosci Lett; 1990 Jul; 115(2-3):345-50. PubMed ID: 2146532 [TBL] [Abstract][Full Text] [Related]
38. Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients. Murtomäki S; Risteli J; Risteli L; Koivisto UM; Johansson S; Liesi P J Neurosci Res; 1992 Jun; 32(2):261-73. PubMed ID: 1404496 [TBL] [Abstract][Full Text] [Related]
39. S-100 immunoreactive interdigitating cells in normal and in Down's syndrome human thymuses. Aita M; Franzé A; Gabrielli F Cell Biol Int Rep; 1991 Aug; 15(8):645-59. PubMed ID: 1835904 [TBL] [Abstract][Full Text] [Related]
40. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]